August 9, 2023: Joe Ali to Lead Seminar on Advancing Justice and Equity in Pragmatic Trials

Headshot of Joe AliOn September 12, Joe Ali, a longtime member of the NIH Pragmatic Trials Collaboratory’s Ethics and Regulatory Core, will present “Advancing Justice and Equity in Pragmatic Clinical Trials.” The presentation is part of the Spotlight on Pain Management series of the VA HSR&D Cyberseminars.

Advance registration is required.

VA HSR&D Cyberseminars: Spotlight on Pain Management
“Advancing Justice and Equity in Pragmatic Clinical Trials”
September 12. 2023; 11:00 am-12:00 noon ET
Joe Ali, PhD
Johns Hopkins University

Advance registration required.

“Pragmatic clinical trials (PCTs) can help bring evidence‐based therapies to people living with pain and co‐occurring conditions, with an emphasis on developing insights that are relevant to patients, practitioners and others. However, in order to reach their potential within a diverse society, pain PCTs must thoughtfully consider how patient vulnerabilities and experiences of injustice and inequity might affect trial design and implementation. Drawing from the experiences and insights of the NIH‐DOD‐VA Pain Management Collaboratory, this seminar will situate the concepts of justice and equity within a pain PCT context, identifying challenges and offering strategies to potentially enhance the value of such trials for various key populations.”

Ali is an associate professor in the Johns Hopkins Bloomberg School of Public Health and the associate director for global programs at the Johns Hopkins Berman Institute of Bioethics. He is a member of the NIH Collaboratory’s Ethics and Regulatory Core.

Register for the seminar today.

Advancing Justice and Equity in Pragmatic Clinical Trials

Headshot of Joe AliVA HSR&D Cyberseminars: Spotlight on Pain Management
“Advancing Justice and Equity in Pragmatic Clinical Trials”
Joe Ali, PhD
Johns Hopkins University

Advance registration required.

“Pragmatic clinical trials (PCTs) can help bring evidence‐based therapies to people living with pain and co‐occurring conditions, with an emphasis on developing insights that are relevant to patients, practitioners and others. However, in order to reach their potential within a diverse society, pain PCTs must thoughtfully consider how patient vulnerabilities and experiences of injustice and inequity might affect trial design and implementation. Drawing from the experiences and insights of the NIH‐DOD‐VA Pain Management Collaboratory, this seminar will situate the concepts of justice and equity within a pain PCT context, identifying challenges and offering strategies to potentially enhance the value of such trials for various key populations.”

Joe Ali is an associate professor in the Johns Hopkins Bloomberg School of Public Health and the associate director for global programs at the Johns Hopkins Berman Institute of Bioethics. He is a member of the NIH Pragmatic Trials Collaboratory’s Ethics and Regulatory Core.

October 12, 2022: Ethics and Regulatory Grand Rounds Series Continues This Friday

Headshots of Joe Ali, Tanya Matthews, and Leslie CroffordThis Friday’s PCT Grand Rounds will feature the next installment of our special Grand Rounds series, Ethical & Regulatory Dimensions of Pragmatic Clinical Trials. Joe Ali, Tanya Matthews, and Leslie Crofford will present “Responding (or Not) to Signals of Potential Clinical Significance in Pragmatic Clinical Trials.”

The Grand Rounds session will be held on Friday, October 14, 2022, at 1:00 pm eastern.

Ali is an assistant professor of international health at Johns Hopkins University, Matthews is director of human research protections at Kaiser Permanente Washington, and Crofford is professor and chair of medicine at Vanderbilt University. Crofford is also a co-principal investigator for FM-TIPS, an NIH Collaboratory Trial.

Join the online meeting.

This special Grand Rounds series will include an additional 4 moderated webinar discussions with panels of experts. The sessions will focus on a range of topics, including the ethics of data sharing; ethical and regulatory considerations in the design and conduct of pragmatic trials; pragmatic research involving patients with dementia; and the use of waivers and alterations of consent. Read the full program.